{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T06:29:20Z","timestamp":1790317760686,"version":"4.1.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:00:00Z","timestamp":1653436800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:00:00Z","timestamp":1653436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiologie"],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:sec>\n                <jats:title>Hintergrund und Ziel<\/jats:title>\n                <jats:p>Eine strukturierte MRT-Befundung  unter Verwendung konsensbasierter inhaltlicher Kategorien hat das Potenzial, die interdisziplin\u00e4re Kommunikation in der Neuroonkologie  zu verbessern. Ziel dieser Studie war es daher, mittels einer bundesweiten Befragung von Mitgliedern medizinischer Fachgesellschaften mit neuroonkologischem Bezug die wesentlichen Befundungskategorien der Bildgebung hirneigener Tumoren aus klinischer Perspektive zu ermitteln.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Material und Methoden<\/jats:title>\n                <jats:p>Auf der Basis eines interdisziplin\u00e4r entwickelten Katalogs von MRT-Befundungselementen wurde ein Online-Fragebogen erstellt. Im Anschluss wurden fach\u00e4rztliche Mitglieder der Deutschen Gesellschaften f\u00fcr Neurochirurgie, Radioonkologie, H\u00e4matologie und Medizinische Onkologie, Neurologie und Neuropathologie  dazu eingeladen, die Items hinsichtlich ihrer klinischen Relevanz zu bewerten.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Ergebnisse<\/jats:title>\n                <jats:p>An der Umfrage nahmen insgesamt 171 Fach\u00e4rzte aus dem Bundesgebiet teil (81\u00a0Neurochirurgen, 66\u00a0Strahlentherapeuten und 24 andere neuroonkologische Experten). Anzahl und anatomische Ausdehnung der Tumoren in einer kontrastmittelverst\u00e4rkten T1- und 2\u2011D-T2-Sequenz (98,8\u202f% vs. 97,1\u202f%) sowie neu diagnostizierte L\u00e4sionen bei Folgeuntersuchungen (T1\u202f+\u2009Kontrast 98,2\u202f%; T2\u00a094,7\u202f%) wurden am h\u00e4ufigsten als essenziell betrachtet. Dar\u00fcber hinaus beurteilten die  Experten insbesondere die Beschreibung einer ependymalen und\/oder leptomeningealen Tumordissemination (93,6\u202f%) sowie Zeichen der Raumforderung inklusive Verschlusshydrozephalus und parenchymale Massenverschiebungen (jeweils &gt;\u202f75,0\u202f%) als wesentlich. Eine standardm\u00e4\u00dfige Erw\u00e4hnung von intratumoralen Verkalkungen, H\u00e4morrhagien, Tumorgef\u00e4\u00dfarchitektur oder erweiterter Bildgebungsmethoden wie MR-Perfusion, Diffusion, Traktographie und Protonenspektroskopie bewertete lediglich eine Minderheit der Umfrageteilnehmer als praxisrelevant.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Schlussfolgerung<\/jats:title>\n                <jats:p>Ein zuweiserorientierter inhaltlicher Mindeststandard der magnetresonanztomographischen Hirntumordiagnostik sollte als klinisch relevante Kernelemente die exakte anatomische Ausbreitung der Raumforderung(en) inklusive ependymaler und meningealer Beteiligung sowie die einschl\u00e4gigen Raumforderungszeichen enthalten.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00117-022-01014-6","type":"journal-article","created":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T12:02:31Z","timestamp":1653480151000},"page":"683-691","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["MRT-Befundung hirneigener Tumoren","MRI reporting of gliomas"],"prefix":"10.1007","volume":"62","author":[{"given":"Torge","family":"Huckhagel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Riedel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,25]]},"reference":[{"key":"1014_CR1","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3389\/fneur.2018.00032","volume":"9","author":"A Bink","year":"2018","unstructured":"Bink\u00a0A, Benner\u00a0J, Reinhardt\u00a0J et\u00a0al (2018) Structured reporting in neuroradiology: intracranial tumors. Front Neurol 9:32. https:\/\/doi.org\/10.3389\/fneur.2018.00032","journal-title":"Front Neurol"},{"key":"1014_CR2","doi-asserted-by":"publisher","first-page":"W134","DOI":"10.2214\/AJR.16.16673","volume":"208","author":"DT Boll","year":"2017","unstructured":"Boll\u00a0DT, Rubin\u00a0GD, Heye\u00a0T, Pierce\u00a0LJ (2017) Affinity chart analysis: a method for structured collection, aggregation, and response to customer needs in radiology. AJR Am J Roentgenol 208:W134\u2013W145. https:\/\/doi.org\/10.2214\/AJR.16.16673","journal-title":"AJR Am. J. Roentgenol."},{"key":"1014_CR3","unstructured":"Brain Tumor Reporting and Data System (BT-RADS) Home. https:\/\/btrads.com\/. Zugegriffen: 27. Dez. 2020"},{"key":"1014_CR4","doi-asserted-by":"publisher","first-page":"CNS28","DOI":"10.2217\/cns-2018-0007","volume":"8","author":"UN Chukwueke","year":"2019","unstructured":"Chukwueke\u00a0UN, Wen\u00a0PY (2019) Use of the response assessment in neuro-oncology (RANO) criteria in clinical trials and clinical practice. CNS Oncol 8:CNS28. https:\/\/doi.org\/10.2217\/cns-2018-0007","journal-title":"CNS Oncol"},{"key":"1014_CR5","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.acra.2018.12.023","volume":"26","author":"A Gore","year":"2019","unstructured":"Gore\u00a0A, Hoch\u00a0MJ, Shu\u00a0H\u2011KG et al (2019) Institutional implementation of a\u00a0structured reporting system: our experience with the brain tumor reporting and data system. Acad Radiol 26:974\u2013980. https:\/\/doi.org\/10.1016\/j.acra.2018.12.023","journal-title":"Acad Radiol"},{"key":"1014_CR6","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/intqhc\/mzg031","volume":"15","author":"K Kelley","year":"2003","unstructured":"Kelley\u00a0K (2003) Good practice in the conduct and reporting of survey research. Int J Qual Health Care 15:261\u2013266. https:\/\/doi.org\/10.1093\/intqhc\/mzg031","journal-title":"Int J Qual Health Care"},{"key":"1014_CR7","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s11060-018-03072-0","volume":"142","author":"M Lee","year":"2019","unstructured":"Lee\u00a0M, Han\u00a0K, Ahn\u00a0SS et\u00a0al (2019) The added prognostic value of radiological phenotype combined with clinical features and molecular subtype in anaplastic gliomas. J\u00a0Neurooncol 142:129\u2013138. https:\/\/doi.org\/10.1007\/s11060-018-03072-0","journal-title":"J Neurooncol"},{"key":"1014_CR8","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis\u00a0DN, Perry\u00a0A, Wesseling\u00a0P et\u00a0al (2021) The 2021 WHO classification of tumors of the central nervous system: a\u00a0summary. Neuro Oncol 23:1231\u20131251. https:\/\/doi.org\/10.1093\/neuonc\/noab106","journal-title":"Neuro Oncol"},{"key":"1014_CR9","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1093\/neuonc\/nou087","volume":"16","author":"QT Ostrom","year":"2014","unstructured":"Ostrom\u00a0QT, Bauchet\u00a0L, Davis\u00a0FG et\u00a0al (2014) The epidemiology of glioma in adults: a\u00a0\u201cstate of the science\u201d review. Neuro Oncol 16:896\u2013913. https:\/\/doi.org\/10.1093\/neuonc\/nou087","journal-title":"Neuro Oncol"},{"key":"1014_CR10","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/nov189","volume":"17","author":"QT Ostrom","year":"2015","unstructured":"Ostrom\u00a0QT, Gittleman\u00a0H, Fulop\u00a0J et\u00a0al (2015) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008\u20132012. Neuro Oncol 17:iv1\u2013iv62. https:\/\/doi.org\/10.1093\/neuonc\/nov189","journal-title":"Neuro Oncol"},{"key":"1014_CR11","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp\u00a0R, Mason\u00a0WP, van den Bent\u00a0MJ et\u00a0al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N\u00a0Engl J Med 352:987\u2013996. https:\/\/doi.org\/10.1056\/NEJMoa043330","journal-title":"N Engl J Med"},{"key":"1014_CR12","unstructured":"The Cancer Imaging Archive (TCIA) (2020) VASARI research project. https:\/\/wiki.cancerimagingarchive.net\/display\/Public\/VASARI+Research+Project. Zugegriffen: 15. Aug. 2021"},{"key":"1014_CR13","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/jmri.26171","volume":"48","author":"SC Thust","year":"2018","unstructured":"Thust\u00a0SC, van den Bent\u00a0MJ, Smits\u00a0M (2018) Pseudoprogression of brain tumors: pseudoprogression of brain tumors. J\u00a0Magn Reson Imaging 48:571\u2013589. https:\/\/doi.org\/10.1002\/jmri.26171","journal-title":"J Magn Reson Imaging"},{"key":"1014_CR14","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s00234-016-1642-9","volume":"58","author":"J Usinskiene","year":"2016","unstructured":"Usinskiene\u00a0J, Ulyte\u00a0A, Bj\u00f8rnerud\u00a0A et al (2016) Optimal differentiation of high- and low-grade glioma and metastasis: a\u00a0meta-analysis of perfusion, diffusion, and spectroscopy metrics. Neuroradiology 58:339\u2013350. https:\/\/doi.org\/10.1007\/s00234-016-1642-9","journal-title":"Neuroradiology"},{"key":"1014_CR15","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.jacr.2018.01.022","volume":"15","author":"BD Weinberg","year":"2018","unstructured":"Weinberg\u00a0BD, Gore\u00a0A, Shu\u00a0H\u2011KG et al (2018) Management-based structured reporting of posttreatment glioma response with the brain tumor reporting and data system. J\u00a0Am Coll Radiol 15:767\u2013771. https:\/\/doi.org\/10.1016\/j.jacr.2018.01.022","journal-title":"J Am Coll Radiol"},{"key":"1014_CR16","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1200\/JCO.2017.72.7511","volume":"35","author":"PY Wen","year":"2017","unstructured":"Wen\u00a0PY, Chang\u00a0SM, Van den Bent\u00a0MJ et al (2017) Response assessment in neuro-oncology clinical trials. J Clin Oncol 35:2439\u20132449. https:\/\/doi.org\/10.1200\/JCO.2017.72.7511","journal-title":"J. Clin. Oncol."},{"key":"1014_CR17","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.acra.2019.07.028","volume":"27","author":"JY Zhang","year":"2020","unstructured":"Zhang\u00a0JY, Weinberg\u00a0BD, Hu\u00a0R et al (2020) Quantitative improvement in brain tumor MRI through structured reporting (BT-RADS). Acad Radiol 27:780\u2013784. https:\/\/doi.org\/10.1016\/j.acra.2019.07.028","journal-title":"Acad Radiol"}],"container-title":["Die Radiologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00117-022-01014-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00117-022-01014-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00117-022-01014-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T09:08:30Z","timestamp":1659344910000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00117-022-01014-6"}},"subtitle":["Was neuroonkologisch t\u00e4tige Kliniker vom Radiologen erwarten","What neuro-oncology clinicians expect from radiologists"],"short-title":[],"issued":{"date-parts":[[2022,5,25]]},"references-count":17,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["1014"],"URL":"https:\/\/doi.org\/10.1007\/s00117-022-01014-6","relation":{},"ISSN":["2731-7048","2731-7056"],"issn-type":[{"value":"2731-7048","type":"print"},{"value":"2731-7056","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,25]]},"assertion":[{"value":"2 May 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"T.\u00a0Huckhagel und C.\u00a0Riedel geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Das Studienprotokoll wurde vorab von der zust\u00e4ndigen Ethikkommission der Universit\u00e4tsmedizin G\u00f6ttingen beraten (Antragsnummer 9\/2\/21). Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren. <i>Consent for publication: <\/i>Nicht zutreffend.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}